InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

Medline Inc.

MDLN Clue Score65
United States Fiscal year ends December CIK 0002046386
$36.26 +1.45% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $36.26 −20.64% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 17 Dec 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2023Revenue23.23Operating income1.25Net income0.23Fiscal year 2024Revenue25.51 +9.8%Operating income2.15Net income1.16 +397.0%Fiscal year 2025Net income1.15 −0.9%Fiscal year 2025Revenue28.43Operating income2.21Net income1.16 +0.5%EPS, diluted−0.01
FY2023FY2024FY2025FY2025
Revenue 23.23 25.51 n/a 28.43
Growth +9.8%
Operating income 1.25 2.15 n/a 2.21
Net income 0.23 1.16 1.15 1.16
Growth +397.0% −0.9% +0.5%
EPS, diluted n/a n/a n/a −0.01
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2023Gross margin25.3%Operating margin5.4%Net margin1.0%Free cash flow margin6.1%Fiscal year 2024Gross margin27.3%Operating margin8.4%Net margin4.6%Free cash flow margin5.5%Fiscal year 2025Fiscal year 2025Gross margin26.4%Operating margin7.8%Net margin4.1%Free cash flow margin4.6%
FY2023FY2024FY2025FY2025
Gross margin 25.3% 27.3% n/a 26.4%
Operating margin 5.4% 8.4% n/a 7.8%
Net margin 1.0% 4.6% n/a 4.1%
Free cash flow margin 6.1% 5.5% n/a 4.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2023Operating cash flow1.69Capital expenditure−0.28Free cash flow1.41Buybacks0.00Fiscal year 2024Operating cash flow1.77Capital expenditure−0.35Free cash flow1.42 +0.4%Buybacks−0.02Fiscal year 2025Fiscal year 2025Operating cash flow1.74Capital expenditure−0.45Free cash flow1.30Buybacks−0.03
FY2023FY2024FY2025FY2025
Operating cash flow 1.69 1.77 n/a 1.74
Capital expenditure −0.28 −0.35 n/a −0.45
Free cash flow 1.41 1.42 n/a 1.30
Growth +0.4%
Buybacks 0.00 −0.02 n/a −0.03

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2023Cash1.59Fiscal year 2024Cash0.20Total debt16.49Net cash (debt)−16.29Fiscal year 2025Fiscal year 2025Cash1.94Total debt12.56Net cash (debt)−10.62Shareholders’ equity10.74Debt to equity1.17
FY2023FY2024FY2025FY2025
Cash 1.59 0.20 n/a 1.94
Total debt n/a 16.49 n/a 12.56
Net cash (debt) n/a −16.29 n/a −10.62
Shareholders’ equity n/a n/a n/a 10.74
Debt to equity n/a n/a n/a 1.17

In billions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In billions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 16 Dec 2025 FY2025 31 Dec 2025
Revenue and profit
23.23 25.51 n/a 28.43
Growth +9.8%
17.35 18.53 n/a 20.91
5.89 6.98 n/a 7.52
Growth +18.5%
0.06 0.07 n/a 0.08
3.87 4.11 n/a 4.52
1.25 2.15 n/a 2.21
Growth +71.7%
0.26 1.25 n/a 1.25
0.03 0.05 n/a 0.09
0.23 1.16 1.15 1.16
Growth +397.0% −0.9% +0.5%
Per share
n/a n/a n/a −0.01
n/a n/a n/a −0.01
Growth
n/a n/a n/a 810.0
n/a n/a n/a 810.0
Growth

Five years in brief

Worked out from the figures above, not from a press release
  • Profitable in every one of the 4 years on file.